Cash Flow

v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash Flows From Operating Activities:    
Net loss $ (12,269,341) $ (8,747,339)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 619,544 379,217
Issuance of common stock for services 68,000 406,020
Amortization of operating lease right-of-use asset 80,112 81,847
Depreciation 305 354
Changes in operating assets and liabilities:    
Prepaid expenses (1,154,792) (5,553)
Deposits 19,031
Accounts payable (723,358) (1,189,182)
Accrued expenses 76,570 (96,234)
Accrued compensation (482,544) (368,812)
Accrued interest 7,907 7,971
Operating lease liability (77,315) (50,158)
Net Cash Used In Operating Activities (13,835,881) (9,581,869)
Cash Flows From Financing Activities:    
Proceeds from sale of NoveCite, Inc. common stock 500
Net proceeds from private placement 18,450,410
Net proceeds from registered direct offering 70,979,842
Net proceeds from common stock warrant exercises 14,242,543 6,027,137
Net Cash Provided By Financing Activities 103,673,295 6,027,137
Net Change in Cash and Cash Equivalents 89,837,414 (3,554,732)
Cash and Cash Equivalents - Beginning of Period 13,859,748 7,893,804
Cash and Cash Equivalents - End of Period 103,697,162 4,339,072
Supplemental Disclosures Of Cash Flow Information and Non-cash Activities:    
Operating lease right-of-use asset and liability recorded upon adoption of ASC 842 $ 1,137,724

Source